Rural Health
News by Topic: Pharmacy and prescription drugs
Dec 13, 2024 - Notice of final rule from the U.S. Department of Health and Human Services (HHS) adopting updated versions of the retail pharmacy standards for electronic transactions adopted under the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). These updated versions are modifications to the currently adopted standards for the following retail pharmacy transactions: healthcare claims or equivalent encounter information; eligibility for a health plan; referral certification and authorization; and coordination of benefits. This final rule also adopts a modification to the standard for the Medicaid pharmacy subrogation transaction. This rule is effective February 11, 2025. Compliance with this rule is required by February 11, 2028.
Source: Federal Register
Dec 12, 2024 - Notice from the U.S. Department of Justice (DOJ) Drug Enforcement Administration (DEA) seeking comments on proposed recordkeeping regulations for emergency medical services (EMS) agencies that handle controlled substances. The Protecting Patient Access to Emergency Medications Act of 2017 amended the Controlled Substances Act to allow for a new registration category for emergency medical services agencies that handle controlled substances. Among other things, the proposed regulations would require an EMS agency to maintain records for each controlled substance administered or disposed of while providing emergency medical services. Comments are due by January 13, 2025.
Source: Federal Register
HHS: 12th Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19
Federal Register
Dec 11, 2024 - Notice of amendment from the Department of Health and Human Services extending the determination of a public health emergency and states that COVID-19 presents a credible risk of a future public health emergency. Among other things, this amendment extends liability immunity for licensed pharmacists, pharmacy interns, and qualified pharmacy technicians to prescribe, dispense, and administer COVID-19 vaccines, seasonal influenza vaccines, and COVID-19 tests through December 31, 2029. This amendment is effective January 1, 2025.
Source: Federal Register
Dec 10, 2024 - Notice of a proposed rule from the Centers for Medicare & Medicaid Services (CMS) revising the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicaid, Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to Star Ratings, marketing and communications, agent/broker compensation, health equity, drug coverage, dual eligible special needs plans (D-SNPs), utilization management, network adequacy, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This proposed rule also includes proposals to codify existing subregulatory guidance in the Part C and Part D programs. Comments are due by January 27, 2025.
Source: Federal Register
Dec 9, 2024 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate program under the Inflation Reduction Act of 2022; 3) updates to the Medicare Diabetes Prevention Program expanded model; 4) payment for dental services inextricably linked to specific covered medical services; 5) updates to drugs and biological products paid under Part B including immunosuppressive drugs and clotting factors; 6) Medicare Shared Savings Program requirements; 7) updates to the Quality Payment Program; 8) Medicare coverage of opioid use disorder services furnished by opioid treatment programs; 9) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 10) electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or an MA-PD plan; 11) updates to the Ambulance Fee Schedule regulations; 12) updates to Clinical Laboratory Fee Schedule regulations; 13) updates to the diabetes payment structure and COVID-19 public health emergency (PHE) flexibilities; 14) expansion of colorectal cancer screening and Hepatitis B vaccine coverage and payment; 15) establishing payment for drugs covered as additional preventive services; and 16) Medicare Parts A and B Overpayment Provisions of the Affordable Care Act and Medicare Parts C and D Overpayment Provisions of the Affordable Care Act. These regulations are effective January 1, 2025.
Source: Federal Register
Dec 9, 2024 - Discusses anticipated challenges with receiving prescription medication for rural Missouri residents relying on the U.S. Postal Service due to planned changes to distribution routes and less frequent service. Notes there have been increases in mail-order prescriptions alongside a national trend in rural pharmacy closures.
Source: Missouri Independent
Dec 4, 2024 - Profiles a rural-based Tennessee pharmacy system, noting the rural health disparities that pharmacy access can help alleviate and the benefits of a community pharmacy.
Source: UTHSC News
HHS: Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Exclusion Authorities
Federal Register
Dec 2, 2024 - Notice of proposed rule from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) that would codify changes made by the Medicaid Services Investment and Accountability Act of 2019 (MSIAA), which added exclusion authorities related to misclassification and false information about outpatient drugs. This proposed rule would also update and clarify OIG's procedures for excluding individuals and entities from participation in the federal healthcare programs, including the factors that will be considered in determining the length of exclusions, the provisions governing notices of exclusions, and certain provisions related to reinstatement into the programs. Comments are due by January 31, 2025.
Source: Federal Register
Nov 26, 2024 - The Department of Justice (DOJ) and Drug Enforcement Administration (DEA) is seeking comments on a requirement regarding the workflow for credentialing healthcare practitioners working independently, in hospitals, or in clinics to prescribe controlled substances electronically. Comments are due January 27, 2025.
Source: Federal Register
VA: Advisory Committee on U.S. Outlying Areas and Freely Associated States, Notice of Meeting
Federal Register
Nov 22, 2024 - The Department of Veterans Affairs (VA) will hold a hybrid public meeting of the Advisory Committee on U.S. Outlying Areas and Freely Associated States on December 10-12, 2024. The agenda will include, among other things, a briefing on the Veterans Benefits Administration (VBA) efforts to assist covered Veterans, family members, caregivers, and survivors; a briefing on the Veterans Health Administration initiatives and updates; the role of the VBA regional offices; prescription drug information; travel funding; and telehealth.
Source: Federal Register